Sanofi (SNY) Other Non-Current Liabilities (2009 - 2025)

Sanofi (SNY) has 17 years of Other Non-Current Liabilities data on file, last reported at $7.8 billion in Q4 2025.

• Quarterly Other Non-Current Liabilities fell 9.81% year-over-year to $7.8 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.8 billion (down 9.81% YoY) and the FY2025 annual result came in at $7.8 billion, down 9.81% from the prior year.
• Other Non-Current Liabilities eased to $7.8 billion in Q4 2025 per SNY's latest filing, from $8.1 billion in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $8.9 billion in Q2 2024, with the low at $1.3 billion in Q4 2022.
• Average Other Non-Current Liabilities over 5 years is $6.7 billion, with a median of $7.9 billion recorded in 2025.
• Year-over-year, Other Non-Current Liabilities fell 28.44% in 2021 and surged 550.2% in 2023.
• Sanofi's Other Non-Current Liabilities stood at $1.3 billion in 2021, then fell by 1.64% to $1.3 billion in 2022, then surged by 550.2% to $8.2 billion in 2023, then gained by 5.77% to $8.7 billion in 2024, then declined by 9.81% to $7.8 billion in 2025.
• Business Quant data shows SNY's Other Non-Current Liabilities at $7.8 billion in Q4 2025, $8.1 billion in Q2 2025, and $8.7 billion in Q4 2024.